Literature DB >> 9765501

The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.

L D Jayanthi1, S Apparsundaram, M D Malone, E Ward, D M Miller, M Eppler, R D Blakely.   

Abstract

A small subset of neurons in the nematode Caenorhabditis elegans utilizes the catecholamine dopamine (DA) as a neurotransmitter to control or modulate movement and egg-laying. Disruption of DA-mediated behaviors represents a potentially powerful strategy to identify genes that are likely to participate in dopaminergic systems in man. In vertebrates, extracellular DA is inactivated by presynaptic DA transport proteins (DATs) that are also major targets of addictive agents, including amphetamines and cocaine. We used oligonucleotides derived from the C. elegans genomic locus T23G5.5 to isolate and characterize T23G5.5 cDNAs. Our studies predict that mRNAs from this locus encode a 615-amino-acid polypeptide with twelve stretches of hydrophobicity suitable for transmembrane domains, similar to that found in vertebrate catecholamine transporters. The inferred translation product bears highest identity (43-47%) to catecholamine (DA, norepinephrine, epinephrine) transporters within the GAT1/NET gene family and possesses conserved residues implicated in amine substrate recognition. Consistent with these findings, HeLa cells transfected with the C. elegans cDNA exhibit saturable and high affinity DA transport (Km = 1.2 microM) that is dependent on extracellular Na+ and Cl- and blocked by inhibitors of mammalian catecholamine transporters, including norepinephrine transporter- and DAT-selective antagonists, tricyclic antidepressants, and the nonselective amine transporter antagonists cocaine and D-amphetamine. These studies validate the T23G5.5 locus as encoding a functional catecholamine transporter, providing important comparative sequence information for catecholamine transporter structure/function studies and a path to identify regulators of dopaminergic signaling via genetic or pharmacologic manipulation of C. elegans cDNA in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765501

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  51 in total

Review 1.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

Review 2.  Dopamine signaling architecture in Caenorhabditis elegans.

Authors:  Paul W McDonald; Tammy Jessen; Julie R Field; Randy D Blakely
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

3.  Swimming Induced Paralysis to Assess Dopamine Signaling in Caenorhabditis elegans.

Authors:  Sirisha Kudumala; Serena Sossi; Lucia Carvelli
Journal:  J Vis Exp       Date:  2019-04-03       Impact factor: 1.355

4.  Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.

Authors:  Osama Refai; Randy D Blakely
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

5.  The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.

Authors:  Julia Bornhorst; Sudipta Chakraborty; Sören Meyer; Hanna Lohren; Sigrid Grosse Brinkhaus; Adam L Knight; Kim A Caldwell; Guy A Caldwell; Uwe Karst; Tanja Schwerdtle; Aaron Bowman; Michael Aschner
Journal:  Metallomics       Date:  2014-01-22       Impact factor: 4.526

6.  Deep conservation of genes required for both Drosphila melanogaster and Caenorhabditis elegans sleep includes a role for dopaminergic signaling.

Authors:  Komudi Singh; Jennifer Y Ju; Melissa B Walsh; Michael A DiIorio; Anne C Hart
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

7.  Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Authors:  Marketa Marvanova; Charles D Nichols
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  An SLC6 transporter of the novel B(0,)- system aids in absorption and detection of nutrient amino acids in Caenorhabditis elegans.

Authors:  Ryan Metzler; Ella A Meleshkevitch; Jeffrey Fox; Hongkyun Kim; Dmitri Y Boudko
Journal:  J Exp Biol       Date:  2013-04-11       Impact factor: 3.312

9.  Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.

Authors:  Lin Chen; Xinbing Wei; Yunfeng Hou; Xiaoqian Liu; Senpeng Li; Baozhu Sun; Xinyong Liu; Huiqing Liu
Journal:  Neurochem Int       Date:  2014-01-22       Impact factor: 3.921

10.  Stimulation of movement in a quiescent, hibernation-like form of Caenorhabditis elegans by dopamine signaling.

Authors:  Marta Maria Gaglia; Cynthia Kenyon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.